
|Videos|June 23, 2015
Benefits of the ACO Model
Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx discusses benefits of the ACO Model.
Advertisement
Sandra Leal, PharmD, MPH, FAPhA, CDE, Vice President for Innovation at SinfoniaRx discusses benefits of the ACO Model.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clinical Manifestations and Prognostic Impact of Anemia in Myelofibrosis
2
Trump Announces Pricing Deals With 9 Drugmakers, Expanding Most-Favored-Nation Drug Pricing Strategy
3
Early RSV Vaccine Uptake Among Older Adults Reveals Significant Access Gaps
4
FDA Approves Nerandomilast for Progressive Pulmonary Fibrosis
5





































































































































































































